Providing investors with the
tools to make informed decisions.
Providing investors with the
tools to make informed decisions.
 Tracking 1053 U.S. listed China Stocks and Counting...
 Tracking 1535 U.S. Stocks and Counting...

 Immunobiotics (PINK:IMBI)

Friday, August 6, 2010
Research

We are speculating that Immunobiotics is planning on entering the Chinese market:

On June 7, 2010, ImmunoBiotics, Inc. entered into an assignment agreement with SYNORx, Inc. whereby SYNORx assigned its Chinese Pending Patent No. 02820470.0 to the Company in exchange for 6,137,500 shares of the Company’s common stock.